Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Spinal Cord Neoplasms 1 Pituitary Neoplasms 1 Parkinson Disease 1 Nervous System Diseases 1 Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Hematologic Diseases 1 Epilepsy 1 Brain Neoplasms 1 Bone Marrow Diseases 1

Interventions

pembrolizumab 39 Bevacizumab 25 Cyclophosphamide 23 Blood Specimen Collection 19 Standard of Care 17 Nivolumab 17 Carboplatin 17 Paclitaxel 15 Exercise 15 Gemcitabine 14 atezolizumab 13 Pemetrexed 13 Cisplatin 13 Radiotherapy 11 Fluorouracil 11 Doxorubicin 11 Cetuximab 10 130-nm albumin-bound paclitaxel 10 durvalumab 9 Rituximab 9 Oxaliplatin 9 Magnetic Resonance Spectroscopy 9 Leucovorin 9 Docetaxel 9 Biopsy 9 abemaciclib 8 Temozolomide 8 Surveys and Questionnaires 8 Prednisone 8 olaparib 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Clinical Laboratory Techniques × 90 days × Clear all

NCT07543432 2026-04-21

STATIC

Stiftelsen Stockholms Sjukhem

Phase NA Recruiting

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡